Literature DB >> 27121876

Genetic and epigenetic landscape of nasopharyngeal carcinoma.

Wei Dai1, Hong Zheng1, Arthur Kwok Leung Cheung2, Maria Li Lung3.   

Abstract

Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy that shows a remarkable geographical and ethic distribution. Multiple factors including predisposing genetic factors, environmental carcinogens, and Epstein-Barr virus (EBV) infection contribute to the accumulation of genetic and epigenetic alterations leading to NPC development. Emerging technologies now allow us to detailedly characterize and understand cancer genomes. Genome-wide studies show that typically NPC tumors are characterized as having comparatively low mutation rates, widespread hypermethylation, and frequent copy number alterations and chromosome abnormalities. In this review, we provide an updated overview of the genetic and epigenetic aberrations that likely drive nasopharyngeal tumor development and progression. We integrate the previous knowledge and novel findings from whole-exome sequencing (WES) and methylome studies in NPC, and further discuss the potential use of these findings to identify biomarkers for NPC diagnosis and prognosis.

Entities:  

Keywords:  Nasopharyngeal carcinoma (NPC); biomarkers; epigenetics; whole-exome sequencing (WES)

Mesh:

Substances:

Year:  2016        PMID: 27121876     DOI: 10.21037/cco.2016.03.06

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  36 in total

Review 1.  The molecular march of primary and recurrent nasopharyngeal carcinoma.

Authors:  Nicholas J Campion; Munira Ally; Bernhard J Jank; Jahangir Ahmed; Ghassan Alusi
Journal:  Oncogene       Date:  2021-01-21       Impact factor: 9.867

2.  Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus.

Authors:  Fang Lu; Andreas Wiedmer; Kayla A Martin; Priyankara J M S Wickramasinghe; Andrew V Kossenkov; Paul M Lieberman
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 3.  Epstein-Barr virus: a master epigenetic manipulator.

Authors:  Rona S Scott
Journal:  Curr Opin Virol       Date:  2017-08-04       Impact factor: 7.090

4.  Contribution of Nitric oxide synthase 3 genetic variants to nasopharyngeal carcinoma risk and progression in a Tunisian population.

Authors:  Sahar Aouf; Ala Laribi; Sallouha Gabbouj; Elham Hassen; Noureddine Bouaouinaa; Abdelfattah Zakhama; Hedi Harizi
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-13       Impact factor: 2.503

5.  LINC01515 promotes nasopharyngeal carcinoma progression by serving as a sponge for miR-325 to up-regulate CDCA5.

Authors:  Dan Liu; Hao Gong; Zezhang Tao; Shiming Chen; Yonggang Kong; Bokui Xiao
Journal:  J Mol Histol       Date:  2021-03-26       Impact factor: 2.611

6.  Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Authors:  Ren-Bo Ding; Ping Chen; Barani Kumar Rajendran; Xueying Lyu; Haitao Wang; Jiaolin Bao; Jianming Zeng; Wenhui Hao; Heng Sun; Ada Hang-Heng Wong; Monica Vishnu Valecha; Eun Ju Yang; Sek Man Su; Tak Kan Choi; Shuiming Liu; Kin Iong Chan; Ling-Lin Yang; Jingbo Wu; Kai Miao; Qiang Chen; Joong Sup Shim; Xiaoling Xu; Chu-Xia Deng
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

7.  Neoantigen landscape in metastatic nasopharyngeal carcinoma.

Authors:  Mei Lin; Xiao-Long Zhang; Rui You; Qi Yang; Xiong Zou; Kai Yu; You-Ping Liu; Ru-Hai Zou; Yi-Jun Hua; Pei-Yu Huang; Jin Wang; Qi Zhao; Xiao-Bing Jiang; Jun Tang; Yang-Kui Gu; Tao Yu; Gui-Ping He; Yu-Long Xie; Zhi-Qiang Wang; Ting Liu; Si-Yuan Chen; Zhi-Xiang Zuo; Ming-Yuan Chen
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

Review 8.  The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both.

Authors:  Edmund Ui-Hang Sim; Choon-Weng Lee; Kumaran Narayanan
Journal:  Biomark Res       Date:  2021-06-30

9.  Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis.

Authors:  Weifeng Wang; Zhuo Zhang; Yundong Li; Anqi Gu; Yingyin Wang; Yizheng Cai; Yajie Yu; Xiaocong Deng
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

10.  Defective HLA class I antigen processing machinery in cancer.

Authors:  Lei Cai; Theodoros Michelakos; Teppei Yamada; Song Fan; Xinhui Wang; Joseph H Schwab; Cristina R Ferrone; Soldano Ferrone
Journal:  Cancer Immunol Immunother       Date:  2018-02-27       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.